NHERF1 and cancer: Some studies show that EBP50 accumulates in the cytoplasm and nuclei of carcinoma cells, acting as an oncogenic agent [12], while other studies demonstrate that higher EBP50 expression could attenuate cancer cell proliferation [13–15].